Impact of pharmacist management of pain, agitation, and delirium in the intensive care unit through participation in multidisciplinary bundle rounds

American Journal of Health-System Pharmacy

Volumn 74, Issue 4, 2017, Pages 253-262

  Louzon, Patricia ^a,b   Jennings, Heath ^b   Ali, Mahmood ^a,c   Kraisinger, Marijo ^a  

^a FLORIDA HOSPITAL   (United States)

^b UNIVERSITY OF FLORIDA HEALTH   (United States)

^c Central Florida Pulmonary Group   (United States)

Author keywords

ABCDE bundle; Delirium; Multidisciplinary; Pharmacist management; Pharmacy ROI

Indexed keywords

ANALGESIC AGENT; BENZODIAZEPINE; DEXMEDETOMIDINE; DOPAMINE; EPINEPHRINE; FENTANYL; LORAZEPAM; MIDAZOLAM; PHENYLEPHRINE; PROPOFOL; SEDATIVE AGENT; HYPNOTIC SEDATIVE AGENT;

ADULT; AGED; ARTICLE; CLINICAL OUTCOME; COHORT ANALYSIS; CONTINUOUS INFUSION; CONTROLLED STUDY; CRITICALLY ILL PATIENT; DRUG COST; FLORIDA; HOSPITAL MORTALITY; HOSPITAL RUNNING COST; HOSPITALIZATION COST; HUMAN; INTENSIVE CARE; INTENSIVE CARE PSYCHOSIS; LENGTH OF STAY; MAJOR CLINICAL STUDY; MECHANICAL VENTILATOR; MEDICAL INTENSIVE CARE UNIT; MIDDLE AGED; PAIN; PHARMACIST; PHYSICIAN; PRIORITY JOURNAL; RESTLESSNESS; RETROSPECTIVE STUDY; SCOPE OF PRACTICE; SEDATION; TEACHING HOSPITAL; VENTILATED PATIENT; AKATHISIA; ANALGESIA; CHEMICALLY INDUCED; CRITICAL ILLNESS; DELIRIUM; FEMALE; INTENSIVE CARE UNIT; MALE; PATIENT CARE; PILOT STUDY; PROCEDURES; PROFESSIONAL STANDARD; TRENDS; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; AKATHISIA, DRUG-INDUCED; CRITICAL ILLNESS; DELIRIUM; FEMALE; HUMANS; HYPNOTICS AND SEDATIVES; INTENSIVE CARE UNITS; LENGTH OF STAY; MALE; MIDDLE AGED; PAIN MANAGEMENT; PATIENT CARE TEAM; PHARMACISTS; PILOT PROJECTS; PROFESSIONAL ROLE; RETROSPECTIVE STUDIES;

EID: 85012897827     PISSN: 10792082     EISSN: 15352900     Source Type: Journal    
DOI: 10.2146/ajhp150942     Document Type: Article

References (20)

1. Horn E, Jacobi J. The critical care pharmacist: Evolution of an essential team member. Crit Care Med. 2006; 34 (suppl 3):24-51.
2. Erstad BL, Haas CE, O'Keeffe T et al. Interdisciplinary patient care in the intensive care unit: focus on the pharmacist. Pharmacotherapy. 2011; 31:128-37.
3. Bond CA, Raehl CL. Clinical pharmacy services, pharmacy staffing, and hospital mortality rates. Pharmacotherapy. 2007; 27:481-93.
4. MacLaren R, Martin S, Fike D, Bond C. Clinical and economic outcomes of involving pharmacists in the direct care of critically ill patients with infections. Crit Care Med. 2008; 36:3184-9.
5. MacLaren R, Bond C. Clinical and economic outcomes of involving pharmacists in the direct care of critically ill patients with thromboembolic or infarction-related events. Pharmacotherapy. 2009; 29:761-8.
6. Papadopoulos J, Rebuck JA, Lober C et al. The critical care pharmacist: An essential intensive care practitioner. Pharmacotherapy. 2002; 22:1484-8.
7. Barr J, Fraser G, Puntillo K et al. Clinical practice guidelines for the management of pain, agitation and delirium in adult patients in the intensive care unit. Crit Care Med. 2013; 41:263-306.
8. Girard TD, Pandharipande PP, Ely EW. Delirium in the intensive care unit. Crit Care. 2008; 12(suppl 3):S3.
9. Kolef MH, Levy NT, Ahrens TS et al. The use of continuous i.v. sedation is associated with prolongation of mechanical ventilation. Chest. 1998; 114:541-8.
10. Devlin JW, Nasraway SA. Reversing oversedation in the intensive care unit: The role of pharmacists in energizing guideline efforts and overcoming protocol fatigue. Crit Care Med. 2008; 36:626-8.
11. Ely EW, Shintani A, Truman B et al. Delirium as a predictor of mortality in mechanically ventilated patients in the intensive care unit. J Am Med Assoc. 2004; 291:1753-62.
12. Pun BT, Ely EW. The importance of diagnosing and managing ICU delirium. Chest. 2007; 132:624-36.
13. Guldbrand P, Berggren L, Brattebo G et al. Survey of routines for sedation of patients on controlled ventilation in Nordic intensive care units. Acta Anaesthesiol Scand. 2004; 48:944-50.
14. Marshall J, Finn CA, Theodore AC. Impact of a clinical pharmacist-enforced intensive care unit sedation protocol on duration of mechanical ventilation and hospital stay. Crit Care Med. 2008; 36:427-44.
15. Chittawatanarat K, Thongshai C. Spontaneous breathing trials with low pressure support protocol for weaning respirator in surgical ICU. J Med Assoc Thai. 2009; 92:1306-12.
16. Rudis MI, Brandl KM, for the Society of Critical Care Medicine and American College of Clinical Pharmacy Task Force on Critical Care Pharmacy Services. Position paper on critical care pharmacy services. Crit Care Med. 2000; 28:3746-50.
17. Brilli RJ, Spevetz A, Branson RD et al. Critical care delivery in the intensive care unit: defining clinical roles and best practice model. Crit Care Med. 2001; 29:2007-9.
18. Haupt MT, Bekes CE, Brilli RJ et al. Guidelines on critical care services and personnel: Recommendations based on a system of categorization of three levels of care. Crit Care Med. 2003; 31:2677-83.
19. Dasta JF, Segal R, Cunningham A. A national survey of critical care pharmaceutical services. Am J Hosp Pharm. 1989; 46:2308-12.
20. MacLaren R, Devlin JW, Martin SJ et al. Critical care pharmacy services in United States hospitals. Ann Pharmacother. 2006; 40:612-8.